Innovation meets cardiovascular trial expertise.
Cardiovascular clinical trials, no matter their size, demand a specialized, experienced cardiovascular CRO to help you navigate the path to success. With unmatched cardiovascular trial experience and new approaches fueled by data and analytics, BioFicher brings agility and speed to trials large and small.
Clinical Experience
BioFicher has contributed to the advancement of Cardiovascular knowledge through participation in hundreds of global studies ranging from the most common tumor types to the rarest of cancers. In collaboration with biopharmaceutical companies and government, we confront the challenges of recruiting from small or geographically sparse patient populations and managing trials that are complex for investigative sites with innovative oncology solutions. Our unique expertise in adaptive/alternative study designs and biostatistics and oncology market research enables us to mitigate some of those challenges for our clients.
169
Studies Conducted
22,612+
Patients Involved
1800+
Site Worldwide
Drive smarter decisions for your cardiovascular trial
Below is a summary of everything we can do to help ensure medical devices for sale in the EU conform to all requirements:
-
Reduce patient burden with Decentralized and Hybrid trial solutions
-
Model and predict event rates with the world’s largest healthcare data source
-
Optimize study protocols by refining eligibility criteria and schedule of assessments
-
Create Direct-to-patient multi-channel recruitment campaigns for rare and common disease populations
-
Enable patient-centered recruitment and tailored site strategies through new technology solutions
-
Monitor safety and efficacy endpoints in near real time with wearables and connected devices
BioFicher's experienced cardio-metabolic drug and medical device development teams support clinical trials across multiple indications, including:
-
NORTH AMERICAHeadquarter 4130 Parklake Ave, # 202, Raleigh, NC 27612 Tell: 984-884-6888 Email: info@bioficher.com
-
LATIN AMERICABuenos Aires, Argentina Avda. Del Libertador 7270, 19th Floor C1429, Buenos Aires C1429 BMS Mexico City, Mexico Gustavo Baz #315 Edificio A-1 Piso 1 Fraccionamiento Industrial La Loma Tlalnepantla, EMEX México City, México C.P. 54060
-
EUROPEAmsterdam, The Netherlands Oval Tower De Entrée 99 197, 14th floor 1101 HE Amsterdam, The Netherlands+31 (0)20 3018 500 Barcelona, Spain L’Illa Diagonal Avenida Diagonal 571-M3-3rd Floor 08029 Barcelona, Spain+34 93 255 5600 Belgrade, Serbia Starine Novaka 23 11000 Belgrade, Serbia +381 11 715 8044 Bucharest, Romania Str. Tudor Arghezi No 8 UNIMED Center Building 6th floor, Room A2
-
ASIA PACIFICAdelaide, Australia Level 24, 91 Westpac House King William St. Adelaide, 5000, Australia Bangkok, Thailand 23/F M Tower, All Seasons Pl 87 Wireless Road Lumpini, Phatumwan Bangkok 10330 Thailand Beijing, China Block C 5th Floor, Yintai Centre No. 2 Jiang Guo Men Wai Street Chaoyang District Beijing, China 100022 Hong Kong Level 23, One Island East 18 Westlands Road Hong Kong Tokyo, Japan Urbannet Nihonbashi 2-Chome Building 5F, 2-1-3 Nihonbashi, Chuo-ku Tokyo 103-0027 Seoul, South Korea 4F, Gangnam N Tower 129 Teheran-ro, Gangnam-gu Seoul, South Korea 06133 Singapore 21 Biopolis Road, #03-03 Nucleos Singapore 138567 Mandaluyong, Philippines BioFicher Sciences Philippines, Inc. 9th Floor, The Podium West Tower 12 ADB Avenue, Ortigas Center Mandaluyong 1555 Philippines
-
MIDDLE EASTMar Roukoz, Lebanon Berytech Technological Pole 1107 2240 Mkalles, Lebanon
-
AFRICALagos State, Nigeria 183 Primerose Tower, Adeola Odeku Street 3rd Ground Floor Lagos State, Nigeria 23401 Bloemfontein, South Africa 183 Nelson Mandela Drive, Ground Floor College Court Bloemfontein, South Africa 9301 Cairo, Egypt Florida Tower El Sheikh Aly Gad El Haq St. 1229 Square, Sheraton Buildings, 8th Floor Heliopolis Cairo, Egypt
-
CARDIOVASCULAR & NEUROVASCULARWe work to deliver innovations that extend and improve the lives of people with cancer.
-
OPHTHAMOLOGYWe work to deliver innovations that extend and improve the lives of people with cancer.
-
INFECTIOUS DISEASES AND VACCINESInfectious Disease research is a dynamic space requiring nimble and innovative solutions. Our team of infectious diseases and vaccines experts respond to the need for speed and flexibility through novel trial design and technology solutions that allow for real-time data delivery.
-
ONCOLOGY & HEMATOLOGYWe work to deliver innovations that extend and improve the lives of people with cancer. Our work in oncology
-
PEDIATRICSWe work to deliver innovations that extend and improve the lives of people with cancer.
-
CELL & GENE THERAPYCell and gene therapies offer tremendous promise where traditional treatments fall short. These innovative therapies require charting new, riskier territory. Our multi-disciplinary cell and gene therapy teams are poised to help you bring life changing treatments to patients earlier.
-
CENTRAL NERVOUS SYSTEMDelivering novel CNS therapies is scientifically, medically and operationally complex. At BioFicher, we have more data and insights than ever before to drive innovation forward. With over three decades of experience across neurology, neurodegenerative diseases, psychiatry, sleep, CNS rare diseases and pain, our CNS team can help you design and deliver complex clinical trials.
-
ALLERGY & RESPIRATORYYour goal is to differentiate and deliver the best respiratory treatment in a competitive arena. Rely on BioFicher’s insightful and actionable analytics and technology platforms to successfully help you meet those challenges.
-
MEDTECH/MEDICAL DEVICEEncompasses our capabilities in digital therapeutics, medical device, and diagnostics — supporting your needs in every therapeutic indication. SCHEDULE A CONSULTATION WITH OUR MEDTECH EXPERT
-
WOMEN HEALTHDisease and treatment impact women differently than men. That’s why women’s health research deserves a specialized approach.
Unique Experience
With a focus on chemotherapies and biologics, BioFicher has contributed to a number of groundbreaking studies including the following:
-
The first peptide to be used in melanoma vaccines
-
Studies with patient populations that have co-morbid conditions like HIV
-
Individualized immunotherapy including CAR-T
-
Gene sequencing in MDS
Challenges of cardiovascular development
-
Pressure to bring down the time and cost of cardiovascular trials
-
Need for fast site activation and recruitment of extremely large patient populations globally
-
Retention of patients to prevent lost to follow-up (LTFU) over the length of the study
-
Analysis of vast amounts of data quickly to detect safety signals and endpoint information
Research with a Purpose
Connected approach to your cardiovascular trials Through our Connected Intelligence approach to cardiovascular development, BioFicher can help you rethink old challenges and surround your trials with a proven suite of capabilities to help you reach milestones faster, deliver programs within budget, and bring game-changing therapies to patients sooner.
Cardiovascular Leaders
At BioFicher Sciences, we value the open exchange of communication between our therapeutic area leaders and your team. We encourage you to contact us to discuss your research plan and determine how we can support your development pathway.
Traci Clemons, Ph.D.
Chief Research Officer
Traci Clemons, Ph.D.
Director and Biostatistician, Ophthalmic Therapeutic and Research Unit